PeopleBio, Inc. (KOSDAQ:304840)
South Korea · Delayed Price · Currency is KRW 1,091.00
-67.00 (-5.79%)
At close: May 20, 2026
PeopleBio Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -15,714 | -10,913 | -16,035 | -14,303 | -4,697 |
Depreciation & Amortization | 1,747 | 1,692 | 1,565 | 1,282 | 734.08 |
Loss (Gain) From Sale of Assets | 2.4 | - | - | -17.65 | -5.17 |
Asset Writedown & Restructuring Costs | 5,981 | 63.62 | - | - | - |
Loss (Gain) From Sale of Investments | -1,108 | 392.52 | 395.43 | - | - |
Loss (Gain) on Equity Investments | 758.25 | 988.33 | 934.89 | 835.96 | 380.5 |
Provision & Write-off of Bad Debts | 100.83 | 84.73 | - | - | - |
Other Operating Activities | 2,157 | -1,580 | 61.43 | 2,299 | -2,450 |
Change in Accounts Receivable | 647.4 | 223.68 | -1,502 | -1,553 | 179.63 |
Change in Inventory | -304.97 | -564.74 | -1,877 | -214 | -156.09 |
Change in Accounts Payable | 242.04 | -104.56 | -156.63 | 259.4 | -157.08 |
Change in Other Net Operating Assets | 307.88 | -1,194 | 331.87 | -2,563 | -661.94 |
Operating Cash Flow | -5,183 | -10,911 | -16,282 | -13,975 | -6,833 |
Capital Expenditures | -213.61 | -78.6 | -719.15 | -1,267 | -1,355 |
Sale of Property, Plant & Equipment | 72 | - | - | 33.25 | 29 |
Cash Acquisitions | -6.75 | - | - | - | 25.73 |
Sale (Purchase) of Intangibles | -110.17 | -36.14 | -41.08 | -73.12 | -35.3 |
Investment in Securities | 5,536 | -578.29 | 2,967 | -10,300 | -2,415 |
Other Investing Activities | 76.69 | 18.83 | -890.93 | 64.94 | -217.79 |
Investing Cash Flow | 5,354 | -674.2 | 1,316 | -11,542 | -3,968 |
Long-Term Debt Issued | 110.95 | 14,850 | - | - | 31,000 |
Long-Term Debt Repaid | -1,464 | -2,694 | -27,048 | -684.16 | -1,333 |
Net Debt Issued (Repaid) | -1,353 | 12,156 | -27,048 | -684.16 | 29,667 |
Issuance of Common Stock | - | - | 29,606 | 1,036 | 12,992 |
Repurchase of Common Stock | - | - | -26.02 | - | - |
Other Financing Activities | - | -0 | -518.45 | -1.75 | 691.99 |
Financing Cash Flow | -1,353 | 12,156 | 2,014 | 350.08 | 43,351 |
Miscellaneous Cash Flow Adjustments | - | -0 | 0 | - | - |
Net Cash Flow | -1,182 | 570.56 | -12,952 | -25,166 | 32,550 |
Free Cash Flow | -5,396 | -10,990 | -17,001 | -15,242 | -8,188 |
Free Cash Flow Margin | -189.30% | -434.27% | -381.80% | -342.91% | -1418.84% |
Free Cash Flow Per Share | -247.93 | -505.52 | -1025.76 | -1041.91 | -510.46 |
Cash Interest Paid | 158.24 | 184.05 | 251.37 | 206.88 | 106.75 |
Cash Income Tax Paid | -2.44 | -22.45 | -16.06 | 54.65 | 5.68 |
Levered Free Cash Flow | -2,761 | -56.87 | -28,889 | -13,378 | 9,824 |
Unlevered Free Cash Flow | -1,074 | 532.67 | -27,390 | -11,516 | 10,532 |
Change in Working Capital | 892.35 | -1,639 | -3,204 | -4,070 | -795.47 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.